Toboni, M., Maxwell, L., Scalise, C. B., Berman, T., Hardesty, M., Ketch, P., … Secord, A. A. (2024). Personalized circulating tumor DNA analysis used for ctDNA detection and response monitoring among patients with advanced or recurrent endometrial cancer. In Gynecologic Oncology (Vol. 190, pp. S208–S209). Elsevier BV. https://doi.org/10.1016/j.ygyno.2024.07.301

Toboni, Michael, Larry Maxwell, Carly Bess Scalise, Tara Berman, Melissa Hardesty, Peter Ketch, Nicole Hook, et al. “Personalized circulating tumor DNA analysis used for ctDNA detection and response monitoring among patients with advanced or recurrent endometrial cancer.” In Gynecologic Oncology, 190:S208–9. Elsevier BV, 2024. https://doi.org/10.1016/j.ygyno.2024.07.301.

Toboni M, Maxwell L, Scalise CB, Berman T, Hardesty M, Ketch P, et al. Personalized circulating tumor DNA analysis used for ctDNA detection and response monitoring among patients with advanced or recurrent endometrial cancer. In: Gynecologic Oncology. Elsevier BV; 2024. p. S208–9.

Toboni, Michael, et al. “Personalized circulating tumor DNA analysis used for ctDNA detection and response monitoring among patients with advanced or recurrent endometrial cancer.” Gynecologic Oncology, vol. 190, Elsevier BV, 2024, pp. S208–09. Crossref, doi:10.1016/j.ygyno.2024.07.301.

Toboni M, Maxwell L, Scalise CB, Berman T, Hardesty M, Ketch P, Hook N, Bridges C, Dutta P, Liu M, Arend R, ElNaggar A, Smitherman C, Secord AA. Personalized circulating tumor DNA analysis used for ctDNA detection and response monitoring among patients with advanced or recurrent endometrial cancer. Gynecologic Oncology. Elsevier BV; 2024. p. S208–S209.